NASDAQ:BTX
Eterna Therapeutics Inc.
- Stock
Last Close
0.20
17/10 04:00
Market Cap
1.05M
Beta: 0.79
Volume Today
2.56M
Avg: 85.42K
PE Ratio
−0.42
PFCF: −0.39
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|
average inventory | -475.50K - | -475.50K 0% | ||||
average payables | 1.51M - | 1.69M 11.39% | 1.34M 20.39% | |||
average receivables | 342K - | 817.50K 139.04% | 688K 15.84% | |||
book value per share | 70.83 - | 3.69 94.79% | 3.00 18.62% | 3.97 32.15% | 0.42 89.41% | |
capex per share | -15.22 - | -0.02 99.88% | -0.07 278.53% | -0.10 36.87% | -0.00 96.33% | |
capex to depreciation | -0.35 - | -0.40 15.24% | -0.34 15.69% | -0.60 78.11% | -0.02 97.17% | |
capex to operating cash flow | -0.40 - | 0.00 101.21% | 0.01 36.19% | 0.01 115.95% | 0.00 93.42% | |
capex to revenue | -0.06 - | -0.28 - | ||||
cash per share | 45.34 - | 0.79 98.27% | 7.84 898.91% | 3.75 52.17% | 1.43 62.00% | |
days of inventory on hand | 50.73 - | |||||
days payables outstanding | 38.86 - | 286.57 - | ||||
days sales outstanding | 22.02 - | 2.28K - | ||||
debt to assets | 0.40 - | 0.41 2.15% | 0.80 96.65% | 0.19 76.77% | 0.18 1.50% | |
debt to equity | 1.19 - | 0.69 42.64% | 3.99 482.06% | 0.34 91.43% | 4.03 1,077.79% | |
dividend yield | 0.00 - | 0.00 - | 0.00 3,576.34% | 0.00 2.71% | ||
earnings yield | -0.32 - | -0.04 87.89% | -0.68 1,627.63% | -2.50 269.40% | -2.27 9.46% | |
enterprise value | 9.15M - | 187.25M 1,947.36% | 166.32M 11.18% | 2.52M 98.49% | 43.83M 1,642.03% | |
enterprise value over ebitda | 4.68 - | -26.19 660.09% | -1.37 94.78% | -0.08 94.25% | -2.24 2,754.10% | |
ev to operating cash flow | 3.33 - | -23.11 793.49% | -7.08 69.36% | -0.12 98.31% | -2.15 1,690.51% | |
ev to sales | 0.46 - | 644.61 - | ||||
free cash flow per share | 22.96 - | -3.92 117.08% | -10.92 178.42% | -6.97 36.14% | -3.84 44.87% | |
free cash flow yield | 0.26 - | -0.04 116.78% | -0.13 199.12% | -2.17 1,553.98% | -2.14 1.38% | |
graham net net | -76.31 - | -1.74 97.72% | -3.89 123.40% | 0.50 112.73% | -7.34 1,581.37% | |
graham number | 213.05 - | 17.08 91.98% | 61.78 261.76% | 26.82 56.59% | 6.21 76.85% | |
income quality | -1.34 - | 1.11 182.89% | 0.19 82.72% | 0.85 344.39% | 0.94 10.36% | |
intangibles to total assets | 0.05 - | 0.62 1,266.28% | 0.27 55.89% | 0.09 66.59% | 0.04 54.65% | |
interest coverage | -4.87 - | -168.56 3,362.95% | -1.53K 810.36% | -1.11K 27.84% | -33.67 96.96% | |
interest debt per share | 88.06 - | 1.42 98.39% | 1.29 8.83% | 1.37 5.76% | 1.81 32.28% | |
inventory turnover | 7.20 - | |||||
invested capital | 1.19 - | 0.38 68.32% | 0.42 10.68% | 0.34 18.39% | 4.03 1,077.79% | |
market cap | 6.33M - | 185.98M 2,840.45% | 180.59M 2.90% | 9.82M 94.56% | 9.57M 2.64% | |
net current asset value | -4.12M - | -3.52M 14.58% | -7.16M 103.73% | 3.51M 149.00% | -37.30M 1,162.98% | |
net debt to ebitda | 1.44 - | -0.18 112.30% | 0.12 166.04% | 0.23 94.79% | -1.75 868.25% | |
net income per share | -28.48 - | -3.51 87.67% | -56.48 1,508.08% | -8.06 85.74% | -4.08 49.39% | |
operating cash flow per share | 38.18 - | -3.90 110.22% | -10.85 177.94% | -6.88 36.62% | -3.84 44.14% | |
payables turnover | 9.39 - | 1.27 - | ||||
receivables turnover | 16.57 - | 0.16 - | ||||
research and ddevelopement to revenue | 0.00 - | 87.06 - | ||||
return on tangible assets | -0.14 - | -1.50 965.91% | -5.20 247.41% | -1.21 76.64% | -0.46 62.12% | |
revenue per share | 275.56 - | 0.01 - | ||||
roe | -0.40 - | -0.95 136.76% | -18.81 1,875.99% | -2.03 89.21% | -9.70 377.97% | |
roic | -0.09 - | -0.87 892.74% | 34.45 4,079.10% | -1.91 105.54% | -0.47 75.44% | |
sales general and administrative to revenue | 214.51 - | |||||
shareholders equity per share | 70.83 - | 3.69 94.79% | 3.00 18.62% | 3.97 32.15% | 0.42 89.41% | |
stock based compensation to revenue | 18.26 - | |||||
tangible asset value | 4.39M - | -375K 108.53% | -2.40M 540.53% | 10.06M 518.94% | 189K 98.12% | |
tangible book value per share | 61.15 - | -0.18 100.30% | -1.11 514.03% | 3.30 397.32% | 0.04 98.92% | |
working capital | -25K - | -1.39M 5,472% | 15.09M 1,183.20% | 6.03M 60.06% | 3.03M 49.79% |
All numbers in USD (except ratios and percentages)